Harel Insurance Investments & Financial Services Ltd. Abb Vie Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$159.82 - $182.1 $269,136 - $306,656	1,684 New	1,684 $307,000
Q1 2023 May 02, 2023	SELL	$144.61 - $166.54 $68,834 - $79,273	-476 Reduced 2.63%	17,590 $2.78 Million
Q4 2022 Jan 26, 2023	SELL	$138.31 - $165.87 $314,655 - $377,354	-2,275 Reduced 11.18%	18,066 $2.93 Million
Q3 2022 Oct 31, 2022	SELL	$134.21 - $153.93 $1.36 Million - $1.56 Million	-10,108 Reduced 33.2%	20,341 $2.86 Million
Q2 2022 Jul 19, 2022	BUY	$137.62 - $174.96 $39,772 - $50,563	289 Added 0.96%	30,449 $4.66 Million
Q1 2022 May 03, 2022	BUY	$131.98 - $163.75 $3.98 Million - $4.94 Million	30,160 New	30,160 $4.89 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $128,916 - $163,116	-1,200 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$106.4 - $120.78 $438,793 - $498,096	-4,124 Reduced 77.46%	1,200 $129,000
Q2 2021 Jul 26, 2021	SELL	$105.21 - $117.21 $256,922 - $286,226	-2,442 Reduced 31.44%	5,324 $1.96 Million
Q1 2021 Apr 27, 2021	SELL	$102.3 - $112.62 $354,776 - $390,566	-3,468 Reduced 30.87%	7,766 $2.81 Million
Q4 2020 Jan 26, 2021	SELL	$80.49 - $108.67 $359,146 - $484,885	-4,462 Reduced 28.43%	11,234 $3.87 Million
Q3 2020 Oct 20, 2020	BUY	$85.91 - $100.83 $1.15 Million - $1.35 Million	13,350 Added 569.05%	15,696 $1.38 Million
Q2 2020 Jul 14, 2020	SELL	$73.37 - $98.18 $7,923 - $10,603	-108 Reduced 4.4%	2,346 $230,000
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $8,707 - $13,201	-135 Reduced 5.21%	2,454 $187,000
Q4 2019 Jan 23, 2020	BUY	$72.13 - $90.25 $186,744 - $233,657	2,589 New	2,589 $229,000
Q1 2019 Apr 18, 2019	SELL	$77.14 - $90.79 $154,280 - $181,580	-2,000 Closed	0 $0
Q1 2018 Apr 30, 2018	SELL	$92.01 - $123.21 $184,020 - $246,420	-2,000 Reduced 50.0%	2,000 $189,000
Q4 2017 Feb 01, 2018	BUY	$89.56 - $98.21 $268,680 - $294,630	3,000 Added 300.0%	4,000 $387,000
Q3 2017 Nov 02, 2017	BUY	$69.85 - $89.22 $69,850 - $89,220	1,000	1,000 $89,000

Others Institutions Holding ABBV

# of Institutions

3,795

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

Vanguard Group Inc Valley Forge, PA

171M
Shares

$29.8 Billion
0.57% of portfolio
Black Rock Inc. New York, NY

136M
Shares

$23.8 Billion
0.54% of portfolio
State Street Corp Boston, MA

77.8M
Shares

$13.6 Billion
0.59% of portfolio
Jpmorgan Chase & CO New York, NY

52.1M
Shares

$9.09 Billion
0.84% of portfolio
Capital International Investors Los Angeles, CA

38.6M
Shares

$6.73 Billion
1.4% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $308B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account